Variants in the alpha2A AR adrenergic receptor gene in psychiatric patients.
In various studies of psychiatric patients, alterations in adrenergic receptor (AR) expression or function have been suggested. Herein, the alpha2A AR gene was screened in 206 patients with schizophrenia, attention deficit hyperactivity disorder (ADHD), autism, alcohol dependence, or cocaine dependence. The entire coding region was examined for single base pair changes, using restriction endonuclease fingerprinting (REF), a screening method that can detect virtually 100% of mutations in 2-kb DNA segments. In the approximately 600 kb of screened sequence, six novel nucleotide changes were identified. The changes resulted in four missense changes (A25G, N251K, R368L, and K370N), and a sequence in the 3' untranslated region. In addition, a silent change (G363G) was found at high frequency in Asians and Native Americans. Of the four missense changes, two found in patients with alcohol/drug dependence occur in highly conserved amino acids, suggesting that these are of likely functional significance. As the alpha2A ARs are widely distributed both pre- and postsynaptically, and as many pharmacological agents with multiple effects target these receptors, the novel missense changes described herein may be candidates for involvement in alcohol/drug dependence, in other clinical disorders or traits, or in differential response to pharmacotherapy.
Feng
J
J
Department of Molecular Genetics, City of Hope National Medical Center, Duarte, California 91010, USA.
Sobell
J L
JL
Heston
L L
LL
Goldman
D
D
Cook
E
E
Kranzler
H R
HR
Gelernter
J
J
Sommer
S S
SS
D000818:Animals; D015894:Genome, Human; D006801:Humans; D009154:Mutation; D011618:Psychotic Disorders / Q000235:genetics*; D018341:Receptors, Adrenergic, alpha-2 / Q000235:genetics*; D017421:Sequence Analysis
D018341:Receptors, Adrenergic, alpha-2